| Product Code: ETC10535982 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Ankylosing Spondylitis Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Ankylosing Spondylitis Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Ankylosing Spondylitis Market - Industry Life Cycle |
3.4 Ireland Ankylosing Spondylitis Market - Porter's Five Forces |
3.5 Ireland Ankylosing Spondylitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Ireland Ankylosing Spondylitis Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Ankylosing Spondylitis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Ankylosing Spondylitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about ankylosing spondylitis |
4.2.2 Growing prevalence of ankylosing spondylitis in Ireland |
4.2.3 Advances in medical research leading to more effective treatment options |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services for ankylosing spondylitis patients |
4.3.2 High treatment costs associated with managing ankylosing spondylitis |
4.3.3 Challenges in early diagnosis and disease management |
5 Ireland Ankylosing Spondylitis Market Trends |
6 Ireland Ankylosing Spondylitis Market, By Types |
6.1 Ireland Ankylosing Spondylitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Ireland Ankylosing Spondylitis Market Revenues & Volume, By NSAIDs, 2021 - 2031F |
6.1.4 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Biologic Drugs, 2021 - 2031F |
6.1.5 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.1.6 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Surgery, 2021 - 2031F |
6.2 Ireland Ankylosing Spondylitis Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Pain & Inflammation, 2021 - 2031F |
6.2.3 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Disease Management, 2021 - 2031F |
6.2.4 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Mobility Improvement, 2021 - 2031F |
6.2.5 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Severe Cases Treatment, 2021 - 2031F |
6.3 Ireland Ankylosing Spondylitis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
6.3.5 Ireland Ankylosing Spondylitis Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
7 Ireland Ankylosing Spondylitis Market Import-Export Trade Statistics |
7.1 Ireland Ankylosing Spondylitis Market Export to Major Countries |
7.2 Ireland Ankylosing Spondylitis Market Imports from Major Countries |
8 Ireland Ankylosing Spondylitis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis |
8.2 Patient adherence to prescribed treatment regimens |
8.3 Number of healthcare professionals trained in ankylosing spondylitis management |
9 Ireland Ankylosing Spondylitis Market - Opportunity Assessment |
9.1 Ireland Ankylosing Spondylitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Ireland Ankylosing Spondylitis Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Ankylosing Spondylitis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Ankylosing Spondylitis Market - Competitive Landscape |
10.1 Ireland Ankylosing Spondylitis Market Revenue Share, By Companies, 2024 |
10.2 Ireland Ankylosing Spondylitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here